StacksVerified U.S. regulatory reference

Part 427 — Medicare Part B Drug Inflation Rebate Program

Subpart A — General Provisions

Subpart B — Determination of Part B Rebatable Drugs

Subpart C — Coinsurance Adjustment and Adjusted Medicare Payment for Part B Rebatable Drugs With Price Increases Faster Than Inflation

Subpart D — Determination of the Rebate Amount for Part B Rebatable Drugs

Subpart E — Reducing the Rebate Amount for Part B Rebatable Drugs in Shortage and When There Is a Severe Supply Chain Disruption

Subpart F — Reports of Rebate Amounts, Reconciliation, Suggestion of Error, and Payments

Subpart G — Enforcement of Manufacturer Payment of Rebate Amounts